Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 07, 2022

SELL
$225.82 - $368.51 $78,359 - $127,872
-347 Closed
0 $0
Q3 2021

Nov 10, 2021

BUY
$221.9 - $484.47 $10,429 - $22,770
47 Added 15.67%
347 $134,000
Q3 2020

Oct 19, 2020

SELL
$54.34 - $94.85 $27,170 - $47,425
-500 Reduced 62.5%
300 $21,000
Q2 2020

Jul 22, 2020

BUY
$29.67 - $80.0 $23,736 - $64,000
800 New
800 $51,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track D'Orazio & Associates, Inc. Portfolio

Follow D'Orazio & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on D'Orazio & Associates, Inc. with notifications on news.